Interval dosing with the HDAC inhibitor vorinostat effectively reverses HIV latency

Title
Interval dosing with the HDAC inhibitor vorinostat effectively reverses HIV latency
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume 127, Issue 8, Pages 3126-3135
Publisher
American Society for Clinical Investigation
Online
2017-07-17
DOI
10.1172/jci92684

Ask authors/readers for more resources

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now